{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:27:13Z","timestamp":1791214033284,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"International University of Health and Welfare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urolithiasis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary hyperoxaluria (PH) is a rare autosomal recessive disorder characterized by an abnormal increase in urinary oxalate excretion. Primary hyperoxaluria type 1 (PH1), the most common PH subtype, is caused by a deficiency of the liver-specific enzyme alanine:glyoxylate aminotransferase, which is localized to peroxisomes. In Japan, the status of PH1 has not been studied in two decades, and few longitudinal studies of PH1 patients have been conducted worldwide. This study aims to analyze the present situation regarding PH1 in Japan. We conducted a literature review of PH1 cases reported in Japan between 2003 and 2023. Twenty patients were diagnosed with PH1 during the study period, including 7 males, 12 females, and 1 patient with an unspecified sex. The median ages at symptom onset and diagnosis were 4.21\u00a0years (range: 0.17\u201347) and 5.5\u00a0years (range: 0.17\u201343), respectively. Ten patients (50%) were diagnosed before age 18, four (44%) of whom had already progressed to end-stage renal disease (ESRD). Among the six patients diagnosed after 18\u00a0years, all had ESRD or progressed to ESRD soon after diagnosis. The overall survival (OS) rate was 81% at 5, 10 and 20\u00a0years post-diagnosis. The mean observation period was 5.62\u00a0years (range: 0\u201332.6). Few longitudinal studies on PH1 patients have been conducted in Japan or worldwide. Over the past 20\u00a0years, the median ages at both symptom onset and diagnosis have significantly decreased, and the OS rate has increased. Early diagnosis and intervention may contribute to better outcomes for PH1 patients in Japan.<\/jats:p>","DOI":"10.1007\/s00240-025-01931-w","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:05:38Z","timestamp":1768550738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Current status of primary hyperoxaluria type 1 in Japan"],"prefix":"10.1007","volume":"54","author":[{"given":"Tomohide","family":"Ogawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Numahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Takeshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromu","family":"Inai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-7688","authenticated-orcid":false,"given":"Tatsuya","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"1931_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0014-5793(86)80563-4","volume":"201","author":"CJ Danpure","year":"1986","unstructured":"Danpure CJ, Jennings PR (1986) Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I. FEBS Lett 201:20\u201324. https:\/\/doi.org\/10.1016\/0014-5793(86)80563-4","journal-title":"FEBS Lett"},{"key":"1931_CR2","doi-asserted-by":"publisher","first-page":"16028","DOI":"10.1074\/jbc.274.23.16028","volume":"274","author":"HH Xue","year":"1999","unstructured":"Xue HH, Sakaguchi T, Fujie M, Ogawa H, Ichiyama A (1999) Flux of the L-serine metabolism in rabbit, human, and dog livers. Substantial contributions of both mitochondrial and peroxisomal serine:pyruvate\/alanine:glyoxylate aminotransferase. J Biol Chem 274:16028\u201316033. https:\/\/doi.org\/10.1074\/jbc.274.23.16028","journal-title":"J Biol Chem"},{"key":"1931_CR3","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/ki.2009.32","volume":"75","author":"B Hoppe","year":"2009","unstructured":"Hoppe B, Beck BB, Miliner DS (2009) The primary hyperoxalurias. Kidney Int 75:1264\u20131271. https:\/\/doi.org\/10.1038\/ki.2009.32","journal-title":"Kidney Int"},{"key":"1931_CR4","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.kint.2019.11.023","volume":"97","author":"DJ Sas","year":"2020","unstructured":"Sas DJ, Enders FT, Mehta RA, Tang X, Zhao F, Seide BM, Milliner DS, Lieske JC (2020) Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening. Kidney Int 97:786\u2013792. https:\/\/doi.org\/10.1016\/j.kint.2019.11.023","journal-title":"Kidney Int"},{"key":"1931_CR5","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1681\/asn.2016030338","volume":"28","author":"A Liebow","year":"2017","unstructured":"Liebow A, Li X, Racie T, Hettinger J, Bettencourt BR, Najafian N, Haslett P, Fitzgerald K, Holmes RP, Erbe D, Querbes W, Knight J (2017) An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria. J Am Soc Nephrol 28:494\u2013503. https:\/\/doi.org\/10.1681\/asn.2016030338","journal-title":"J Am Soc Nephrol"},{"key":"1931_CR6","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ekir.2021.01.029","volume":"6","author":"G Ariceta","year":"2021","unstructured":"Ariceta G, Barrios K, Brown BD, Hoppe B, Rosskamp R, Langman CB (2021) Hepatic lactate dehydrogenase A: an RNA interference target for the treatment of all known types of primary hyperoxaluria. Kidney Int Rep 6:1088\u20131098. https:\/\/doi.org\/10.1016\/j.ekir.2021.01.029","journal-title":"Kidney Int Rep"},{"key":"1931_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000086361","volume":"25","author":"T Takayama","year":"2005","unstructured":"Takayama T, Nagata M, Ichiyama A, Ozono S (2005) Primary hyperoxaluria type 1 in Japan. Am J Nephrol 25:297\u2013302. https:\/\/doi.org\/10.1159\/000086361","journal-title":"Am J Nephrol"},{"key":"1931_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3165\/jjpn.28.60","volume":"28","author":"Y Mori","year":"2015","unstructured":"Mori Y, Tamamura S, Yamada K, Ohto T, Watanabe Y, Taniguchi Y, Hayashi T, Shigematsu Y (2015) Primary hyperoxaluria type 1 and end-stage renal disease in a 3-month-old infant. Jpn J Pediatr Nephrol 28:60\u201367. https:\/\/doi.org\/10.3165\/jjpn.28.60","journal-title":"Jpn J Pediatr Nephrol"},{"key":"1931_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbrc.2023.01.042","volume":"645","author":"L Gatticchi","year":"2023","unstructured":"Gatticchi L, Dindo M, Pampalone G, Conter C, Cellini B, Takayama T (2023) Biochemical and cellular effects of a novel missense mutation of the AGXT gene associated with primary hyperoxaluria type 1. Biochem Biophys Res Commun 645:118\u2013123. https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.042","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl 8","key":"1931_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ndt\/10.supp8.3","volume":"10","author":"P Cochat","year":"1995","unstructured":"Cochat P, Deloraine A, Rotily M, Olive F, Liponski I, Deries N (1995) Epidemiology of primary hyperoxaluria type 1 Soci\u00e9t\u00e9 de n\u00e9phrologie and the soci\u00e9t\u00e9 de n\u00e9phrologie p\u00e9diatrique. Nephrol Dial Transplant 10(Suppl 8):3\u20137. https:\/\/doi.org\/10.1093\/ndt\/10.supp8.3","journal-title":"Nephrol Dial Transplant"},{"key":"1931_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00467-006-0124-4","volume":"21","author":"P Cochat","year":"2006","unstructured":"Cochat P, Liutkus A, Fargue S, Basmaison O, Ranchin B, Rolland MO (2006) Primary hyperoxaluria type 1: still challenging! Pediatr Nephrol 21:1075\u20131081. https:\/\/doi.org\/10.1007\/s00467-006-0124-4","journal-title":"Pediatr Nephrol"},{"key":"1931_CR12","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.transproceed.2004.07.024","volume":"36","author":"AA Al-Eisa","year":"2004","unstructured":"Al-Eisa AA, Samhan M, Naseef M (2004) End-stage renal disease in Kuwaiti children: an 8-year experience. Transplant Proc 36:1788\u20131791. https:\/\/doi.org\/10.1016\/j.transproceed.2004.07.024","journal-title":"Transplant Proc"},{"key":"1931_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s004670050143","volume":"10","author":"A Kamoun","year":"1996","unstructured":"Kamoun A, Lakhoua R (1996) End-stage renal disease of the Tunisian child: epidemiology, etiologies, and outcome. Pediatr Nephrol 10:479\u2013482. https:\/\/doi.org\/10.1007\/s004670050143","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"1931_CR14","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1007\/s00467-003-1234-x","volume":"18","author":"B Hoppe","year":"2003","unstructured":"Hoppe B, Langman CB (2003) A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol 18(10):986\u2013991. https:\/\/doi.org\/10.1007\/s00467-003-1234-x","journal-title":"Pediatr Nephrol"},{"key":"1931_CR15","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/ndt\/18.2.273","volume":"18","author":"CS van Woerden","year":"2003","unstructured":"van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA (2003) Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 18:273\u2013279. https:\/\/doi.org\/10.1093\/ndt\/18.2.273","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"1931_CR16","first-page":"385","volume":"23","author":"T Gargah","year":"2012","unstructured":"Gargah T, Khelil N, Youssef G, Karoui W, Lakhoua MR, Abdelmoula J (2012) Primary Hyperoxaluria Type 1 in Tunisian Children. Saudi J Kidney Dis Transpl 23(2):385\u2013390","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1931_CR17","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/ki.2014.222","volume":"86","author":"G Mandrile","year":"2014","unstructured":"Mandrile G, van Woerden CS, Berchialla P, Beck BB, Bourdain CA, Hulton SA, Rumsby G (2014) Data from a large European study indicate that the outcome of primary hyperoxaluria type 1 correlates with the AGXT mutation type. Kidney Int 86:1197\u20131204","journal-title":"Kidney Int"},{"issue":"1","key":"1931_CR18","first-page":"30","volume":"8","author":"N Rhuma","year":"2020","unstructured":"Rhuma N, Elazibi M, Elhamadi M, Tilmon M (2020) The pattern of Primary Hyperoxaluria Type I in Libyan children at Tripoli Children Hospital, (1998\u20132018). Tripolitana Med J 8(1):30\u201334","journal-title":"Tripolitana Med J"},{"issue":"3","key":"1931_CR19","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40620-022-01258-4","volume":"35","author":"G Mandrile","year":"2022","unstructured":"Mandrile G, Pelle A, Sciannameo V, Benetti E, D\u2019Alessandro MM, Emma F, Montini G, Peruzzi L, Petrarulo M, Romagnoli R, Vitale C, Cellini B, Giachino D (2022) Primary hyperoxaluria in Italy: the past 30 years and the near future of a (not so) rare disease. J Nephrol 35(3):841\u2013850. https:\/\/doi.org\/10.1007\/s40620-022-01258-4","journal-title":"J Nephrol"},{"issue":"1","key":"1931_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00240-023-01494-8","volume":"51","author":"J Wu","year":"2023","unstructured":"Wu J, Song J, He Y, Zhong C, Yang Q, Li Q, Wang M (2023) Case series and literature review of primary hyperoxaluria type 1 in Chinese patients. Urolithiasis 51(1):123. https:\/\/doi.org\/10.1007\/s00240-023-01494-8","journal-title":"Urolithiasis"},{"key":"1931_CR21","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/ndt\/10.12.2224","volume":"10","author":"N Kopp","year":"1995","unstructured":"Kopp N, Leumann E (1995) Changing pattern of primary hyperoxaluria in Switzerland. Nephrol Dial Transplant 10:2224\u20132227. https:\/\/doi.org\/10.1093\/ndt\/10.12.2224","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"1931_CR22","first-page":"56","volume":"11","author":"DS Milliner","year":"1998","unstructured":"Milliner DS, Wilson DM, Smith LH (1998) Clinical expression and long-term outcomes of primary hyperoxaluria types 1 and 2. J Nephrol 11(Suppl 1):56\u201359","journal-title":"J Nephrol"},{"key":"1931_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1385\/cbb:32:1-3:171","volume":"32","author":"A Ichiyama","year":"2000","unstructured":"Ichiyama A, Oda T, Maeda-Nakai E (2000) Primary hyperoxaluria type 1 in Japan. Cell Biochem Biophys 32:171\u2013176. https:\/\/doi.org\/10.1385\/cbb:32:1-3:171","journal-title":"Cell Biochem Biophys"},{"key":"1931_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1046\/j.1464-410x.2001.00064.x","volume":"87","author":"S Lewandowski","year":"2001","unstructured":"Lewandowski S, Rodgers A, Schloss I (2001) The influence of a high-oxalate\/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects. BJU Int 87:307\u2013311. https:\/\/doi.org\/10.1046\/j.1464-410x.2001.00064.x","journal-title":"BJU Int"},{"key":"1931_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/s0022-5347(05)64545-4","volume":"168","author":"AL Rodgers","year":"2002","unstructured":"Rodgers AL, Lewandowski S (2002) Effects of 5 different diets on urinary risk factors for calcium oxalate kidney stone formation: evidence of different renal handling mechanisms in different race groups. J Urol 168:931\u2013936. https:\/\/doi.org\/10.1016\/s0022-5347(05)64545-4","journal-title":"J Urol"},{"key":"1931_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/s0090-4295(99)00617-2","volume":"55","author":"CR Powell","year":"2000","unstructured":"Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE, Leslie SW (2000) Impact of body weight on urinary electrolytes in urinary stone formers. Urology 55:825\u2013830. https:\/\/doi.org\/10.1016\/s0090-4295(99)00617-2","journal-title":"Urology"}],"container-title":["Urolithiasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-025-01931-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00240-025-01931-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-025-01931-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:05:39Z","timestamp":1768550739000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00240-025-01931-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1931"],"URL":"https:\/\/doi.org\/10.1007\/s00240-025-01931-w","relation":{},"ISSN":["2194-7236"],"issn-type":[{"value":"2194-7236","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"19 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study used data from published literature; therefore, no ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study used data from published literature; therefore, no ethical approval was required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"34"}}